Bristol-Myers Squibb

Adexanet Alfa reverses anticoagulant effect of Eliquis in first stage of Phase 3
Seeking Alpha
Mon, 11/17/14 - 10:55 am
Eliquis
bloodthinners
Adexanet Alfa
Portola Pharmaceuticals
Pfizer
Bristol-Myers Squibb
Bristol-Myers Squibb to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland
Yahoo
Fri, 11/14/14 - 07:57 am
Bristol-Myers Squibb
drug manufacturing
Bristol-Myers Gives Updates on HCV Candidate Daclatasvir
Yahoo/Zacks.com
Wed, 11/12/14 - 08:33 am
Bristol-Myers Squibb
hepatitis C
daclatasvir
Are Expensive Biotech Drugs Bad For Business?
Seeking Alpha
Tue, 11/11/14 - 10:53 am
drug pricing
biotech
AbbVie
AstraZeneca
Bristol-Myers Squibb
Dendreon
Gilead Sciences
GSK
Merck
Novartis
Teva Pharmaceutical
Vertex Pharmaceuticals
ALLY Trial Demonstrates High Cure Rates for Investigational Daclatasvir and Sofosbuvir Combination among Genotype 3 Hepatitis C Patients
Yahoo/BusinessWire
Sat, 11/8/14 - 11:35 am
daclatasvir
sofosbuvir
hepatitis C
hepatitis
Bristol-Myers Squibb
Bristol-Myers Plan to Widen Access to its Hep C Drug is Criticized
WSJ Pharmalot
Mon, 11/3/14 - 03:40 pm
Bristol-Myers Squibb
hepatitis C
Daklinza
daclatasvir
Bristol-Myers beefs up fibrosis pipeline with $444M option deal
Fierce Biotech
Mon, 11/3/14 - 09:28 am
Bristol-Myers Squibb
Galecto Biotech
Denmark
M&A
IPF
idiopathic pulmonary fibrosis
Bristol immunotherapy shows promise in lung cancer trial
Yahoo/AP
Thu, 10/30/14 - 09:58 am
Bristol-Myers Squibb
non-small cell lung cancer
nivolumab
Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy
Yahoo
Tue, 10/28/14 - 10:28 am
Bristol-Myers Squibb
F-star Alpha
breast cancer
Merck grabs another 'breakthrough' in PD-1 lung cancer race with Bristol-Myers
Fierce Biotech
Mon, 10/27/14 - 09:10 am
Merck
Bristol-Myers Squibb
anti-PD-1 immunotherapy
lung cancer
Keytruda
Bristol-Myers beats 3Q earnings and revenue expectations
Yahoo/AP
Fri, 10/24/14 - 07:45 am
Bristol-Myers Squibb
earnings
AbbVie Kills Shire Merger, But Door Opens for Bristol-Myers Squibb?
TheStreet.com
Fri, 10/17/14 - 09:15 am
AbbVie
Shire
M&A
Bristol-Myers Squibb
Should Gilead Sciences, inc. Fear Incoming Competition?
Motley Fool
Wed, 10/15/14 - 02:51 pm
Gilead Sciences
hepatitis C
AbbVie
Bristol-Myers Squibb
The top 10 most expensive drugs of 2013
Fierce Pharma
Tue, 10/14/14 - 10:05 am
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
Bristol-Myers, Otsuka ask judge to nix Abilify kickback suit
Fierce Pharma
Mon, 10/13/14 - 10:26 am
Bristol-Myers Squibb
Otsuka
kickbacks
Abilify
whistleblower lawsuits
Bristol-Myers, Pharmacyclics And Janssen Collaborate On OPDIVO And IMBRUVICA
RTT News
Mon, 10/13/14 - 10:14 am
Bristol-Myers Squibb
Pharmacyclics
Janssen
Opdivo
Imbruvica
Companies That Could Develop An Enterovirus Treatment
Yahoo/Benzinga
Mon, 10/13/14 - 09:16 am
enterovirus
AbbVie
Alnylam
Gilead Sciences
Bristol-Myers Squibb
Merck
Biocryst
Chimerix
Tekmira
Sarepta Therapeutics
Gilead Sciences: Here Comes the Competition
Barron's
Tue, 10/7/14 - 01:21 pm
Gilead Sciences
hepatitis C
Sovaldi
Merck
AbbVie
Idenix
Bristol-Myers Squibb
Achillion
Bristol-Myers Squibb pulls FDA filing for asunaprevir, citing rapidly evolving hepatitis C field
First Word Pharma
Tue, 10/7/14 - 08:48 am
Bristol-Myers Squibb
asunaprevir
hepatitis C
Novartis works with Bristol-Myers Squibb to test lung cancer drugs
Yahoo/Reuters
Mon, 10/6/14 - 07:29 am
Novartis
Bristol-Myers Squibb
lung cancer
Opdivo

Pages